EGRX Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology.

$44.45  +1.33 (3.08%)
As of 06/30/2022 15:59:48 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2014
Outstanding shares:  12,738,592
Average volume:  135,612
Market cap:   $546,358,211
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJH7VB4
Valuation   (See tab for details)
PE ratio:   15.32
PB ratio:   2.54
PS ratio:   2.22
Return on equity:   23.47%
Net income %:   20.59%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy